Filing Manager
CVI Investments, Inc.
Reporting Manager
CVI Investments, Inc.
Symbol
APVO
Shares outstanding
3,225,806 shares
Disclosed Ownership
200,000 shares
Ownership
6.2%
Form type
SCHEDULE 13G
Filing time
10 Apr 2025, 10:14:57 UTC
Date of event
03 Apr 2025

Sponsored

Quoteable Key Fact

"CVI Investments, Inc. disclosed 6.2% ownership in Aptevo Therapeutics Inc. Common Stock, $0.001 par value per share (APVO) on 03 Apr 2025."

Quick Takeaways

  • CVI Investments, Inc. filed SCHEDULE 13G for Aptevo Therapeutics Inc. Common Stock, $0.001 par value per share (APVO).
  • Disclosed ownership: 6.2%.
  • Date of event: 03 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Apr 2025, 10:14.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CVI Investments, Inc. 6.2% 200,000 0 200,000 /s/ Brian Sopinsky Brian Sopinsky, Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc. 6.2% 200,000 0 200,000 /s/ Brian Sopinsky Brian Sopinsky, Secretary